Sign In
Section Navigation
Common TitlePACTG 1051
Official Title Multiple-dose, Open-label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination With Low-dose Ritonavir in HIV-infected Pediatric Patients
Phase Phase I
ClinicalTrials.gov NCT00076999
Treatments
Tipranavir
Tipranavir Aptivus

Tipranavir

Tradename:AptivusOther Names:TPVClass:Protease Inhibitors (PI)
Categories Resistance/Virological FailurePharmacologyTreatment-ExperiencedAdverse EffectsPediatrics
Funding
IndustryBoehringer Ingelheim
References
  • Salazar JC, Cahn P, Della Negra M, et al. Efficacy and safety of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents: 5 years of experience. Pediatr Infect Dis J. 2014;33:396-400.
    [PubMed Abstract]
  • Salazar JC, Cahn P, Yogev R, et al. Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents. AIDS. 2008;22:1789-98.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.